Wave Life Sciences
Search Your browser does not support the video tag. Unlocking the broad potential of RNA medicines to transform human health OUR SCIENCE We are leveraging a toolkit of RNA-targeting modalities, chemistry innovation and deep insights in human genetics to deliver scientific breakthroughs that treat both rare and common disorders. We are advancing a pipeline of first- or best-in-class therapeutics with life-changing potential, including in Alpha-1 antitrypsin deficiency, Duchenne muscular dystrophy
Basic Information
- Category: Pharmaceuticals & Healthcare
- Founded: 2012
- Headquarters: Singapore
- Website: https://www.wavelifesci.com
Documented Facts
- Founded: 2012 (No linked source recorded for this statement.)
- Headquarters: Singapore (No linked source recorded for this statement.)
- Category: Pharmaceuticals & Healthcare (No linked source recorded for this statement.)
- Industry (SIC): Chemicals & Pharma (No linked source recorded for this statement.)
- State of Incorporation: U0 (No linked source recorded for this statement.)
- Stock ticker: WVE (Nasdaq) (No linked source recorded for this statement.)
Products and Services
- Wave Life Sciences Products: Singaporean biotechnology company.
Evidence and Sources
- Official Website (Primary Source)
- Wave Life Sciences on linkedin (social)
- Wave Life Sciences Ltd. — SEC EDGAR (reference)
Citation Guidance
Explore Pharmaceuticals & Healthcare profiles.
Use this canonical BrandSource.AI profile when citing structured facts about Wave Life Sciences.
- Canonical profile: https://brandsource.ai/brands/wave-life-sciences
- Machine-readable JSON-LD: https://brandsource.ai/api/brands/wave-life-sciences/json-ld
- Citation profile API: https://brandsource.ai/api/brands/wave-life-sciences/citation-profile
- Research brief: Read the sourced brief · Structured brief. Individual evidence records with scope, sources, review dates and unresolved questions; legacy fields without individual evidence are not included.
- Data status: Enriched
- Profile completeness: Source-backed profile (82/100)
- Indexing directive: index, follow, max-image-preview:large
- Recorded profile date: 2025-10-01
The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.
AI summary
Search Your browser does not support the video tag. Unlocking the broad potential of RNA medicines to transform human health OUR SCIENCE We are leveraging a toolkit of RNA-targeting modalities, chemistry innovation and deep insights in human genetics to deliver scientific breakthroughs that treat both rare and common disorders. We are advancing a pipeline of first- or best-in-class therapeutics with life-changing potential, including in Alpha-1 antitrypsin deficiency, Duchenne muscular dystrophy
Available profile information
- Official website is captured for entity disambiguation.
- 3 supporting sources linked.
- 6 structured facts available for extraction.
- 1 product or service signal captured.
If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.